Less than 28 days of intravenous antibiotic treatment is sufficient for suppurative thrombophlebitis in injection drug users

Clinical Infectious Diseases

Volumn 46, Issue 5, 2008, Pages 741-744

  Mertz, Dominik ^a   Khanlari, Bettina ^a   Viktorin, Nina ^a   Battegay, Manuel ^a   Fluckiger, Ursula ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CILASTATIN PLUS IMIPENEM; FLUCLOXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANALYTIC METHOD; ANTIBIOTIC THERAPY; ARCANOBACTERIUM HEMOLYTICUM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMORAL VEIN; HOSPITAL ADMISSION; HUMAN; ILIAC VEIN; INJECTION; INTERNAL JUGULAR VEIN; MALE; PEPTOSTREPTOCOCCUS ASACHAROLYTICUS; PRIORITY JOURNAL; SAPHENOUS VEIN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS PYOGENES; SUBCLAVIAN VEIN; THROMBOPHLEBITIS; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; SUBSTANCE ABUSE; TIME; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HOSPITALIZATION; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS; THROMBOPHLEBITIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 39749110656     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/527445     Document Type: Article

References (12)

1. Scheidegger C, Zimmerli W. Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users. AIDS 1996; 10:1407-14.
2. Andes DR, Urban AW, Acher CW, Maki DG. Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter. Am J Med 1998; 105:446-50.
3. Chirinos JA, Garcia J, Alcaide ML, Toledo G, Baracco GJ, Lichtstein DM. Septic thrombophlebitis: diagnosis and management. Am J Cardiovasc Drugs 2006; 6:9-14.
4. Falagas ME, Vardakas KZ, Athanasiou S. Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: a systematic review. Eur J Pharmacol 2007; 557:93-8.
5. Kniemeyer HW, Grabitz K, Buhl R, Wust HJ, Sandmann W. Surgical treatment of septic deep venous thrombosis. Surgery 1995; 118:49-53.
6. Fah F, Zimmerli W, Jordi M, Schoenenberger RA. Septic deep venous thrombosis in intravenous drug users. Swiss Med Wkly 2002; 132:386-92.
7. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-72.
8. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:394-434.
9. Cohen Y, Tit A, Brauner M, Fosse JP, Hoang P. Contribution of computerized tomography to the diagnosis of catheter-induced septic central venous thrombosis. Intensive Care Med 1996; 22:1279-80.
10. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55.
11. Dans PE, Matricciani RM, Otter SE, Reuland DS. Intravenous drug abuse and one academic health center. JAMA 1990; 263:3173-6.
12. Mertz D, Frei R, Jaussi B, et al. Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin Infect Dis 2007; 45:475-7.